Tempest Therapeutics (NASDAQ:TPST) Given New $7.00 Price Target at Scotiabank
Tempest Therapeutics (NASDAQ:TPST – Free Report) had its price objective decreased by Scotiabank from $13.00 to $7.00 in a research report report published on Friday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. Separately, HC Wainwright cut their price target on shares of Tempest Therapeutics from $47.00 to $16.00 and set a […]
Tempest Therapeutics (NASDAQ:TPST – Free Report) had its price objective decreased by Scotiabank from $13.00 to $7.00 in a research report report published on Friday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. Separately, HC Wainwright cut their price target on shares of Tempest Therapeutics from $47.00 to $16.00 and set a […]
